skip to Main Content
About Us
People
Publications
Innovation
News
Support Us
Opportunities
Contact
Search
Open Mobile Menu
Search
Submit
Publications
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
December 23, 2020
barry
Share This
Tweet
Share
Share
Email
previous post:
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy
next post:
Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation
Back To Top
×